Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 12/31/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Edward M. Sellers

Wrong Dr. Edward M. Sellers?

President and Principal

Phone: (416) ***-****  HQ Phone
DL Global Partners Inc
Suite 100 78 Baby Point Cres.
Toronto , Ontario M6S 2C1

Company Description: DL Global Partners Inc. is an international consortium of consultants, key opinion leaders and services supporting drug and device development for disorders of the...   more

Employment History

Board Memberships and Affiliations


  • MD
  • PhD
  • University of Toronto
  • PhD.
  • M.D.
  • Ph.D.
  • Harvard University
  • Faculty of Medicine
137 Total References
Web References
Edward Sellers, M.D., ..., 31 Dec 2015 [cached]
Edward Sellers, M.D., Ph.D
Founder and President of DL Global Partners, and Professor Emeritus of Pharmacology, Medicine and Psychiatry at University of Toronto, Canada
DL Global Partners Inc. - Contact Us, 5 May 2015 [cached]
Edward M. Sellers President and Principal DL Global Partners Inc.
Intellipharmaceutics - Intellipharmaceutics Augments Its Rexista(TM) Oxycodone Development Program With Novel Overdose Deterrence Technology, 28 Aug 2014 [cached]
Dr. Ed Sellers, an internationally recognized clinical pharmacologist and Professor Emeritus, University of Toronto, and President of DL Global Partners commented "The risk of overdose due to taking more opiate analgesic than prescribed is a real one.
DL Global Partners Inc. - About Us, 5 May 2015 [cached]
Edward M. Sellers, MD, PhD, FRCPC, FACP President and Principal, DL Global Partners Inc.
An internationally recognized authority on clinical psychopharmacology, pharmacogenetics and smoking, abuse liability assessment and substance abuse. Dr. Sellers has been active in basic and applied science for over 40 years. During this time, he has published more than 350 peer reviewed papers and has been cited more than 23,000 times. He has a broad base of experience as an academic, hospital and CRO industry executive. During his career he has made not only pivotal scientific contributions but also, through his leadership and ability to problem solve, has been instrumental in successfully building programs, units and businesses. He is a founder of DecisionLine Clinical Research, Nicogen Inc. and ValleVista Natural Health Inc. As an independent consultant he has worked with academic institutions, hospitals, government agencies, investors and biopharmaceutical and device companies achieving a deep understanding of their needs. Areas of current focus include accelerating early stage drug development through new methods, optimizing strategies to assess abuse potential of new and re-formulated drugs and regulatory risk management and application of abuse liability methodology to modified risk tobacco related products.
After receiving his MD (Toronto 1965), PhD (Harvard 1971) and Internal Medicine specialty certification (1972), Dr. Sellers began his scientific career at the University of Toronto in 1972 and rapidly rose to the rank of full Professor as he established the world's foremost clinical psychopharmacology unit which trained many of today's leaders in the field. During this period he also became responsible for the operations of the Clinical Institute of the Addiction Research Foundation, one of the world's largest and best known research and treatment organizations in the substance abuse field. With increasingly senior appointments at the University of Toronto, for a period of five years he was responsible for all of the academic programs at the Faculty of Medicine University of Toronto.
In 1997, he co-founded and served as President and CEO of DecisionLine Clinical Research Corporation which grew to be a world leading early stage CRO focused on CNS drug development with over 80 beds and 220 employees until acquired in 2008 by Kendle International.
In 2010, he founded DL Global Partners Inc. He sits on numerous Scientific Advisory Boards of pharmaceutical and device companies and recently chaired the Scientific Advisory Panel on Opiate Analgesic Abuse for the Therapeutic Products Directorate, Health Canada.
Dr. Sellers has received numerous awards including the Rawls Palmer Progress in Medicine Award (1987 ASCPT); Nathan B. Eddy Award 2012 CPDD; Oscar B Hunter Award (2014 ASCPT).
Scientists Profiles, 27 Dec 2010 [cached]
Edward M. Sellers
Dr. Edward M. Sellers
Dr. Sellers is the Vice President of Kendle Early Stage - Toronto. Prior to June 2008 he was President and CEO of DecisionLine Clinical Research Corporation until it was acquired by Kendle International. Kendle Early Stage - Toronto provides drug development consulting and support services and conducts early stage drug trials. The company's principal areas of expertise are Phase I studies involving measurement of pharmacodynamics of CNS drugs. The Toronto unit is recognized worldwide as the leader in conduct of human abuse liability studies critical to international and national scheduling decisions.
Dr. Sellers is a graduate of the University of Toronto, Faculty of Medicine (M.D. 1965) and Harvard University (Ph.D. 1971, Pharmacology) and is a certified specialist in Internal Medicine in Canada and the United States. He is a Professor Emeritus of Pharmacology, Medicine and Psychiatry at the University of Toronto. He is an internationally recognized scientist having published more than 600 articles, chapters and monographs. His research covers a wide range of basic and clinical sciences including drug and alcohol dependence, pharmacogenetics, drug metabolism and kinetics.
Dr. Sellers is a member of numerous national and international editorial boards, governmental advisory committees and international organizations including the World Health Organization Expert Advisory Committee on Drug Dependence. He has been President of the American Society for Clinical Pharmacology and Therapeutics, the Canadian Society for Clinical Pharmacology and the College on the Problems of Drug Dependence.
He has received numerous awards including the prestigious Rawls-Palmer Award for Progress in Medicine of the American Society for Clinical Pharmacology and Therapeutics and the Senior Investigator and Service Awards of the Canadian Society of Clinical Pharmacology. This latter award was in recognition of his leadership role in having Clinical Pharmacology recognized as a Specialty by the Royal College of Physicians and Surgeons of Canada.
Dr. Edward Sellers named as one of the "Notable People in R & D" by R & D Directions magazine.
Dr. Edward M. Sellers Vice President, Early Stage, Toronto Senior Scientist, Kendle International
Other People with the name "Sellers":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.